Comparison of Overall Survival, Recurrence, and Metastasis in Breast Cancer Patients Aged 70 Years and Older Undergoing Breast-Conserving Surgery Versus Total Mastectomy: A Retrospective Cohort Study
Main Article Content
Abstract
Background: The surgical management of breast cancer requires balancing oncological control with quality of life, particularly in elderly patients (≥70 years) where treatment de-escalation via Breast Conserving Surgery (BCS) is increasingly favored. This study evaluates the real-world comparative outcomes of BCS versus Total mastectomy in this specific context.
Objective: To compare Disease-Free Survival (DFS) and Overall Survival (OS) between non-metastatic breast cancer patients aged 70 years and older undergoing Total mastectomy versus Breast Conserving Surgery (BCS) at Buri Ram Hospital.
Methodology: A retrospective cohort study was conducted on 146 breast cancer patients (122 Total mastectomy, 24 BCS). Baseline characteristics were compared using T-tests. Survival outcomes were analyzed using the Kaplan-Meier method and Log-rank test.
Results: Patients in the Total mastectomy group had significantly larger mean tumor sizes compared to the BCS group (3.38 cm vs. 2.31 cm, p=0.002). However, long-term survival analysis revealed no statistically significant difference in Overall Survival (OS Log-rank p=0.756) or Disease-Free Survival (DFS Log-rank p=0.405) between the two surgical modalities.
Conclusions: BCS offers non-inferior survival outcomes compared to total mastectomy in appropriately selected candidates, supporting its continued use as a preferred option for early-stage breast cancer.
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347(16):1233-41. doi: 10.1056/NEJMoa022152.
Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002;347(16):1227-32. doi: 10.1056/NEJMoa020989.
Litière S, Werutsky G, Fentiman IS, Rutgers E, Christiaens MR, Van Limbergen E, et al. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol 2012;13(4):412-9. doi: 10.1016/S1470-2045(12)70042-6.
van de Water W, Bastiaannet E, Scholten AN, Kiderlen M, de Craen AJ, Westendorp RG, et al. Breast-conserving surgery with or without radiotherapy in older breast patients with early stage breast cancer: a systematic review and meta-analysis. Ann Surg Oncol 2014;21(3):786-94. doi: 10.1245/s10434-013-3374-y.
Hughes KS, Schnaper LA, Berry D, Cirrincione C, McCormick B, Shank B, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 2004;351(10):971-7. doi: 10.1056/NEJMoa040587.
Hwang ES, Lichtensztajn DY, Gomez SL, Fowble B, Clarke CA. Survival after lumpectomy and mastectomy for early stage invasive breast cancer: the effect of age and hormone receptor status. Cancer 2013;119(7):1402-11. doi: 10.1002/cncr.27795.
Gradishar WJ, Moran MS, Abraham J, Abramson V, Aft R, Agnese D, et al. Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2024;22(5):331-57. doi: 10.6004/jnccn.2024.0035.